Fresenius Medical Care AG (FMS) Gains from Investment Securities (2010 - 2025)

Fresenius Medical Care AG's Gains from Investment Securities history runs 16 years deep, the most recent figure standing at -$88.7 million for Q3 2025.

• In Q3 2025, Gains from Investment Securities rose 17.92% year-over-year to -$88.7 million; the TTM figure through Sep 2025 stood at -$318.6 million (up 36.93% YoY), while the FY2020 annual figure was $188.1 million, down 33.08% from the prior year.
• Gains from Investment Securities was -$88.7 million for Q3 2025 at Fresenius Medical Care AG, down from -$87.5 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of -$21.5 million in Q1 2024 to a low of -$231.8 million in Q2 2024.
• Historically, Gains from Investment Securities has averaged -$97.0 million across 5 years, with a median of -$87.5 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities plunged 296.59% in 2023, then soared 62.27% in 2025.
• A 5-year view of Gains from Investment Securities shows it stood at -$68.6 million in 2021, then surged by 47.18% to -$36.3 million in 2022, then slumped by 296.59% to -$143.8 million in 2023, then climbed by 24.88% to -$108.0 million in 2024, then gained by 17.92% to -$88.7 million in 2025.
• The last three Gains from Investment Securities figures came in at -$88.7 million (Q3 2025), -$87.5 million (Q2 2025), and -$34.5 million (Q1 2025), per Business Quant data.